Shanghai Composite (SSEC.NDX)

Close: 3 295.06 (-2.23), Apr 25, 2025
Hold

Automatic technical analysis. Long term, Apr 25, 2025

Shanghai Composite has broken the ceiling of the falling trend in the long term, which indicates a slower initial falling rate. The index has given a positive signal from the rectangle formation by a break up through the resistance at 3128. Further rise to 3675 or more is signaled. The index has support at points 3170 and resistance at points 3400. The index is overall assessed as technically neutral for the long term.

Recommendation one to six quarters: Hold

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.74%0.41-0.07%
5 days-1.122.58%0.40+0.56%
22 days-28.807.12%0.46-2.22%
66 days-8.5714.37%8.41-1.69%

More analyses of Shanghai Composite

chart Shanghai Composite (SSEC) Candlesticks 22 Days
Candlesticks
chart Shanghai Composite (SSEC) Short term
Short term: Hold
chart Shanghai Composite (SSEC) Medium term
Medium term: Hold
chart Shanghai Composite (SSEC) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.